AVITA Medical (RCEL) Short-term Investments (2021 - 2025)

AVITA Medical's Short-term Investments history runs 5 years deep, the most recent figure standing at $7.9 million for Q4 2025.

• Quarterly Short-term Investments fell 63.63% year-over-year to $7.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.9 million (down 63.63% YoY) and the FY2025 annual result came in at $7.9 million, down 63.63% from the prior year.
• Short-term Investments was $7.9 million for Q4 2025 at AVITA Medical, up from $7.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $66.9 million in Q4 2023 and bottomed at $3.5 million in Q2 2025.
• A 5-year average of $33.7 million and a median of $29.7 million in 2021 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments surged 178.13% — and 2025, when it plunged 90.51%.
• AVITA Medical's Short-term Investments stood at $29.6 million in 2021, then surged by 106.34% to $61.2 million in 2022, then climbed by 9.42% to $66.9 million in 2023, then slumped by 67.38% to $21.8 million in 2024, then sank by 63.63% to $7.9 million in 2025.
• Business Quant data shows RCEL's Short-term Investments at $7.9 million in Q4 2025, $7.9 million in Q3 2025, and $3.5 million in Q2 2025.